Cost-Effectiveness of Early Treatment with Originator Biologics or Their Biosimilars After Methotrexate Failure in Patients with Established Rheumatoid Arthritis

Advances in Therapy, 2019, 36, 2086-2095

Citation of paper, Cost-Effectiveness of Early Treatment with Originator Biologics or Their Biosimilars After Methotrexate Failure in Patients with Established Rheumatoid Arthritis

Authors Citing This Paper

Author	Citing Papers	Author's Papers	Author's Citations	Author's IF
Seyyed Meysam Abtahi Froushani	1	36	239	1.4
Arunachalam Chinnathambi	1	140	2,854	5.5

Journals Citing This Paper

Journal	Citing Papers	Journal's IF	Journal's Star
Advances in Therapy	2	4.1	★★★
PharmacoEconomics & Outcomes News	1	0.1
Arabian Journal of Chemistry	1	5.9
Life Sciences	1	6.8	★★★

Quick Tips

This is an overview of where and by who this paper has been cited.

Help Us

Non-profit projects normally ask for donations. We don't. We will survive one way or another. If you wish to help us, please spread the word to let more people use this service.

It is delightful to see our efforts are useful to a broad range of researchers.